cilostazol has been researched along with Brain Swelling in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the non-rtPA cohort, pretreatment by cilostazol significantly decreased the endothelial expression of adhesion molecules (P-selectin and intercellular adhesion molecule-1) and prevented platelet aggregation and leukocyte plugging in the microvessels after cerebral ischemia/reperfusion in the acute phase." | 7.78 | Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. ( Fujita, Y; Hase, Y; Ihara, M; Ito, H; Kitamura, A; Maki, T; Nakabayashi, H; Okamoto, Y; Takahashi, R; Washida, K, 2012) |
| "Oral treatment with cilostazol 30 mg/kg two times at 5 min and 4 h significantly suppressed the hemispheric lesion area and volumes when detected by ADC, T2 images and histology, but 3 and 10 mg/kg cilostazol were without effect." | 5.32 | Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI study. ( Fukunaga, M; Hong, KW; Hosokawa, T; Ishikawa, M; Koga, K; Lee, JH; Lee, YK; Miyakoda, G; Mori, T, 2003) |
| "In the non-rtPA cohort, pretreatment by cilostazol significantly decreased the endothelial expression of adhesion molecules (P-selectin and intercellular adhesion molecule-1) and prevented platelet aggregation and leukocyte plugging in the microvessels after cerebral ischemia/reperfusion in the acute phase." | 3.78 | Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. ( Fujita, Y; Hase, Y; Ihara, M; Ito, H; Kitamura, A; Maki, T; Nakabayashi, H; Okamoto, Y; Takahashi, R; Washida, K, 2012) |
| "Oral treatment with cilostazol 30 mg/kg two times at 5 min and 4 h significantly suppressed the hemispheric lesion area and volumes when detected by ADC, T2 images and histology, but 3 and 10 mg/kg cilostazol were without effect." | 1.32 | Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI study. ( Fukunaga, M; Hong, KW; Hosokawa, T; Ishikawa, M; Koga, K; Lee, JH; Lee, YK; Miyakoda, G; Mori, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hase, Y | 1 |
| Okamoto, Y | 1 |
| Fujita, Y | 1 |
| Kitamura, A | 1 |
| Nakabayashi, H | 1 |
| Ito, H | 1 |
| Maki, T | 1 |
| Washida, K | 1 |
| Takahashi, R | 1 |
| Ihara, M | 1 |
| Lee, JH | 1 |
| Lee, YK | 1 |
| Ishikawa, M | 1 |
| Koga, K | 1 |
| Fukunaga, M | 1 |
| Miyakoda, G | 1 |
| Mori, T | 1 |
| Hosokawa, T | 1 |
| Hong, KW | 1 |
2 other studies available for cilostazol and Brain Swelling
| Article | Year |
|---|---|
Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
Topics: Administration, Oral; Animals; Antigens, CD; Brain; Brain Edema; Brain Ischemia; Calcium-Binding Pro | 2012 |
Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI study.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Cilostazol; Magnetic Resonance Imaging; Male; Rats; Rat | 2003 |